论文部分内容阅读
目的研究并分析脑梗死患者超敏C反应蛋白、纤维蛋白原的检测及其临床意义。方法我院2年期间,即2010年8月1日至2012年8月1日期间共收治了脑梗死患者62例,并将同期同年龄范围的健康体检者62例作为对照组,测定上述两组患者超敏C反应蛋白和纤维蛋白原的水平。结果观察组患者的超敏C反应蛋白和纤维蛋白原分别为(13.9±2.25)mg/L和(8.25±2.81)g/L,与对照组患者超敏C反应蛋白和纤维蛋白原水平之间的差异具统计学意义(P<0.05)。观察组患者超敏C反应蛋白和纤维蛋白原水平越高,患者的梗塞面积越大,差异具有统计学意义(P<0.05)。病情程度不同的脑梗死患者,超敏C反应蛋白和纤维蛋白原的水平越高,则患者的病情越危重,差异具有统计学意义(P<0.05)。结论积极监测脑梗死患者的超敏C反应蛋白和纤维蛋白原水平有助于预测患者梗塞的面积和病情程度,值得推广。
Objective To study and analyze the detection of high-sensitivity C-reactive protein and fibrinogen in patients with cerebral infarction and its clinical significance. Methods A total of 62 patients with cerebral infarction were treated in our hospital during 2 years, that is, from August 1, 2010 to August 1, 2012. Sixty-two healthy subjects in the same age range were taken as control group. Group Hypersensitivity C-reactive protein and fibrinogen levels. Results The levels of Hs-CRP and fibrinogen in the observation group were (13.9 ± 2.25) mg / L and (8.25 ± 2.81) g / L, respectively, The difference was statistically significant (P <0.05). The higher the level of hypersensitive C-reactive protein and fibrinogen in the observation group, the larger the infarct size of patients, the difference was statistically significant (P <0.05). Patients with different degrees of cerebral infarction, high-sensitivity C-reactive protein and fibrinogen levels, the more serious the patient’s condition, the difference was statistically significant (P <0.05). Conclusion Active monitoring of Hs-CRP and fibrinogen levels in patients with cerebral infarction is helpful to predict the infarct size and severity in patients with cerebral infarction. It is worth promoting.